- $747.80m
- $410.05m
- $110.49m
- 46
- 29
- 44
- 33
Annual income statement for Xencor, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 123 | 275 | 165 | 175 | 110 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 199 | 232 | 247 | 307 | 309 |
| Operating Profit | -76.8 | 43 | -82.6 | -132 | -199 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -69.3 | 82.6 | -54.5 | -120 | -235 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -69.3 | 82.6 | -55.2 | -133 | -237 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -69.3 | 82.6 | -55.2 | -133 | -233 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -69.3 | 82.6 | -55.2 | -133 | -233 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.21 | 1.38 | -0.924 | -2.19 | -3.35 |